Cargando…
CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future
In recent years, with the breakthrough of CAR-T cells in the treatment of hematological tumors, they are increasingly being used to treat solid tumors, including urologic neoplasms. There are many relatively specific targets for urologic neoplasms, especially prostate cancer. Besides, urologic neopl...
Autores principales: | Zhang, Zhengchao, Li, Dong, Yun, Heng, Liu, Wei, Chai, Keqiang, Tong, Jie, Zeng, Tongwei, Gao, Zhenghua, Xie, Yongqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292130/ https://www.ncbi.nlm.nih.gov/pubmed/35860578 http://dx.doi.org/10.3389/fonc.2022.915171 |
Ejemplares similares
-
Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
por: Zhang, Zhengchao, et al.
Publicado: (2022) -
Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
por: Su, Pengxiao, et al.
Publicado: (2023) -
Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future
por: Zhang, Zhengchao, et al.
Publicado: (2021) -
Special Chimeric Antigen Receptor (CAR) Modifications of T Cells: A Review
por: Miao, Lele, et al.
Publicado: (2022) -
The past, present, and future of urological quality improvement collaboratives
por: Reese, Adam C., et al.
Publicado: (2021)